GO:1901798 positive regulation of signal transduction by p53 class mediator

GO:1901798, positive regulation of signal transduction by p53 class mediator, is a Gene Ontology biological process term that captures any event which activates or increases the frequency, rate or extent of signal transduction mediated by a p53 class protein. In practical terms, it is the annotation used when a researcher wants to describe a positive input into the p53 signaling axis, rather than the downstream transcriptional output itself. The term is therefore central to studies of stress-responsive signaling, because p53 class mediators act as nodes that convert diverse cellular stresses into coordinated changes in gene expression and cell fate. Understanding how this positive regulation is achieved is important for cancer biology, where p53 pathway integrity is a major determinant of tumor suppression and therapeutic response. It is also relevant to computational and systems-level studies that reconstruct signaling networks from gene expression data, because GO:1901798 provides a standardized way to label positive regulatory edges in those networks. The sections below define the term, outline its mechanistic logic, list the genes and proteins most often associated with it, and describe experimental strategies for studying it in human cell models.

GO:1901798 is defined by QuickGO as any process that activates or increases the frequency, rate or extent of signal transduction by a p53 class mediator. In other words, it is a positive regulatory biological process whose substrate is the signaling activity of a p53 family protein, and whose effect is to enhance that signaling rather than to inhibit it. The term is not restricted to a single upstream stimulus or a single downstream effector; it is a general annotation for positive control of p53-class signal transduction.

GO:1901798 matters because positive regulation of p53 class signaling is a decisive step in determining whether a cell mounts a protective stress response or undergoes pathological transformation. Because p53 class mediators are among the most frequently altered pathways in human cancer, annotating and experimentally testing positive regulators of this axis is directly relevant to understanding tumor suppression and to identifying candidate therapeutic targets.

The following genes and proteins are commonly studied in the context of positive regulation of p53 class signaling, based on published pathway and network analyses.

Positive regulation of p53 class signaling is itself regulated by upstream kinases, ubiquitin ligases and feedback loops that control the stability and activity of p53 family proteins. Computational and network pharmacology studies have been used to infer these regulatory relationships from gene expression data, helping to distinguish positive regulators from negative feedback components.

Loss or attenuation of p53 class signaling is a common feature of many human cancers, making positive regulators of this pathway important candidate tumor suppressors. Experimental models that restore or enhance p53 class signaling are widely used to study tumor suppression mechanisms.

SMAD proteins and AMPK-related kinases such as MPK38/MELK have been shown to regulate metabolic and inflammatory signaling, providing a link between p53 class signaling and metabolic disease.

Comparative gene co-expression network analysis of dengue and Zika virus infection in human neural progenitor cells has been used to identify host signaling modules, including stress-responsive pathways that intersect with p53 class signaling.

RNA sequencing after perturbation of candidate regulators can identify downstream transcriptional changes associated with positive regulation of p53 class signaling.

Gene co-expression network analysis has been used to infer regulatory relationships and to identify modules linked to p53 class signaling in infection and disease models.

Single nucleotide polymorphism analysis and biocomputation have been applied to predict functional impacts of variants in p53 pathway genes.

Inhibitor studies, such as those targeting PLK1, can reveal how chemical perturbation alters p53 class signaling and cell fate.

Researchers studying positive regulation of signal transduction by p53 class mediator-related genes often need to determine whether a candidate gene is causally involved in pathway activity, and this requires well-controlled genetic perturbation models.

GO:1901798 provides a precise ontology label for positive inputs into p53 class signaling, a process that is central to stress responses and cancer biology. By combining CRISPR perturbation models with transcriptomic and network-based readouts, researchers can systematically identify and validate regulators of this pathway. EDITGENE supports these efforts with knockout, point-mutation, knock-in, overexpression and library screening services tailored to p53 class signaling research.